Energroup Holdings Corp (OTC: ENHD) is a diversified holding company focused on acquiring and managing assets in emerging ...

ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) reports that it has now completed the sale of its 68% share ownership interest in Achieve Behavioral Health Greenville LLC, (“Achieve”) as ...

Aegis Capital Corp. is acting as the sole book-running manager for the Offering on a firm commitment basis. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 2:15 pm PT. The ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of ...

Interested parties may access a live webcast and replay of the presentation by visiting the Inari Medical investor relations website. About Inari Medical, Inc. Patients first. No small plans. Take ...

To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be ...

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, ...

PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the development and commercialization of KETARX™ (Ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, ...

The option was issued on January 3, 2025, and has an exercise price equivalent to the closing price of the Company’s common stock on the date of grant. The option vests in equal proportions on a ...

The options are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a stock option agreement covering the grant. LENSAR is a commercial-stage medical ...

The warrants, if exercised for cash following the Stockholder Approval (as defined in the securities purchase agreement), will result in up to $1.85 million additional gross proceeds to Carmell.